Document Detail


An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
MedLine Citation:
PMID:  22537024     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The bacterium Neisseria meningitidis of serogroups A and W-135 has in the recent decade caused most of the cases of meningococcal meningitis in the African meningitis belt and there is currently no efficient and affordable vaccine available demonstrated to protect against both these serogroups. Previously, deoxycholate extracted outer membrane vesicle (OMV) vaccines against serogroup B meningococci have been shown to be safe and induce protection in humans in clonal outbreaks. The serogroup A and W-135 strains isolated from meningitis belt epidemics demonstrate strikingly limited variation in major surface-exposed protein structures. We have here investigated whether the OMV vaccine strategy also can be applied to prevent both serogroups A and W-135 meningoccal disease. A novel vaccine combining OMV extracted from recent African serogroup A and W-135 strains and adsorbed to aluminium hydroxide was developed and its antigenic characteristics and immunogenicity were studied in mice. The specificity of the antibody responses was analysed by immunoblotting and serum bactericidal assays (SBA). Moreover, the bivalent A+W-135 vaccine was compared with monovalent A and W-135 OMV vaccines. The bivalent OMV vaccine was able to induce similar SBA titers as the monovalent A or W-135 OMV towards both serogroups. High SBA titers were also observed against a meningococcal serogroup C strain. These results show that sub-capsular antigens may be of importance when developing broadly protective and affordable vaccines for the meningitis belt.
Authors:
Gunnstein Norheim; Gro Tunheim; Lisbeth M Naess; Paul Arne Kristiansen; Dominique A Caugant; Einar Rosenqvist
Related Documents :
22554644 - Current epidemiology of rubella and congenital rubella syndrome in australia: progress ...
22559114 - Mucosal immune response in newborn holstein calves that had maternally derived antibodi...
22862954 - First-in-man application of a novel therapeutic cancer vaccine formulation with the cap...
22464934 - Comparison of attitudes about polio, polio immunization, and barriers to polio eradicat...
12180104 - Ecology and physiology of infectious bacteria--implications for biotechnology.
15993924 - Cyanobacteria and earthy/musty compounds found in commercial catfish (ictalurus punctat...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-26
Journal Detail:
Title:  Scandinavian journal of immunology     Volume:  -     ISSN:  1365-3083     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0323767     Medline TA:  Scand J Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.
Affiliation:
Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway Faculty of Medicine, University of Oslo, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel hybrid comprehensive two-dimensional - multi-dimensional gas chromatography for precise, hig...
Next Document:  Prognostic Value of Capnography During Rest and Exercise in Patients With Heart Failure.